Management of endocrine disease: Present and future perspectives for medical therapy of nonfunctioning pituitary adenomas

Yona Greenman*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

In contrast to the clear indication for surgical treatment in symptomatic patients with clinically nonfunctioning pituitary adenomas (NFPA), there are no randomized controlled studies comparing therapeutic strategies such as watchful waiting, irradiation or medical therapy for the management of NFPA after surgery. Further, no medical therapy is currently approved for the treatment of NFPA. In this review, we summarize accumulating data on medications currently approved for secreting pituitary adenomas, used off-label in patients with NFPA. Perspectives on overall treatment optimization and potential future therapies are also detailed.

Original languageEnglish
Pages (from-to)R113-R124
JournalEuropean Journal of Endocrinology
Volume177
Issue number3
DOIs
StatePublished - Sep 2017

Fingerprint

Dive into the research topics of 'Management of endocrine disease: Present and future perspectives for medical therapy of nonfunctioning pituitary adenomas'. Together they form a unique fingerprint.

Cite this